Implication of Human Microbiota on the Gut Inflammatory Diseases

This study discusses the implication of human microbiota on gut inflammatory diseases like Crohn’s disease and ulcerative colitis. It covers topics like dysbiosis, microbiome, and health intervention by microbiota manipulation. The study material, solved assignments, essays, and dissertations on Desklib can help students understand the subject better.

Running head: SCIENTIFIC PRACTICE AND COMMUNICATION
Implication of Human Microbiota on the Gut Inflammatory Diseases
Name of the Student:
Name of the University:
Author Note:

1SCIENTIFIC PRACTICE AND COMMUNICATION
Abstract
Inflammatory bowel disease is a perfect example of gut-microbe disease. Inflammatory bowel
disease can be described as the recurring, persistent, idiopathic, and a multifactoral
gastrointestinal inflammation. Whereas the two most common type of Inflammatory bowel
disease are: Crohn’s disease and ulcerative colitis. In the Crohn’s disease it has been seen that
the inflammation occurs along the gastro-intestinal tract. While the in ulcerative colitis, the
inflammation is restricted only to the large intestine. The incidence of the gastro-intestinal
inflammation is due to the imbalances in the population of the gut microbes. The gastrointestinal
cells are protected by a mucus covering and it consists of the mucus glycoproteins which is
synthesized by the goblet cells. These goblet cells get directly affected by the release of bioactive
factors mucus are secreted during the process of fermentation by the microorganisms that are
beneficial. The intestinal microbes have the potential to directly affect the goblet cells and it led
to gut inflammation diseases.
Keywords: Gastrointestinal cells, Epithelial cells, dysbiosis, gut microbes, inflammation,
ulcerative colitis, Crohn’s disease

2SCIENTIFIC PRACTICE AND COMMUNICATION
Table of Contents
Introduction......................................................................................................................................3
Discussion........................................................................................................................................3
Literature review..............................................................................................................................4
Microbiome and its metabolites in disease and health................................................................4
Gut inflammatory disease............................................................................................................5
Dysbiosis and disease..................................................................................................................6
Health intervention by microbiota manipulation.........................................................................7
Conclusion.......................................................................................................................................8
Reference.......................................................................................................................................10
Appendix........................................................................................................................................13

3SCIENTIFIC PRACTICE AND COMMUNICATION
Introduction
The human gut micro biota plays a major in the wellbeing of the human host and the
diverse nature of the microbes is both beneficial and harmful for the humans. The most common
microbes that are found to be interacting with the human immune system are the eukaryotes,
viruses and bacteria and this plays an influential role in the development of diseases. Studies
have indicated that a human body harbors about 100 trillion microbial cells. Thus, it is no
denying that the human microbiota plays a decisive role in the both the maintenance of health
and development of diseases (Scher et al. 2015). The microbiota is described to be involved in
the harvesting of energy and its storage though a variety of metabolic functions which includes
the absorption of undigested carbohydrates and fermentation of the undigested food. Thus, the
evolutionary process played a key role in establishment of the microbes as human symbionts.
However, one of the important aspects of human microbiota is the interaction of the microbiota
with the immune system. The human microbiota helps in the signaling and promoting the
maturation of the immune cells and the development of the immune functions (Kostic, Xavier
and Gevers 2014). This study is based on the implication of human microbiota on the gut
inflammatory diseases.
Discussion
Identification of the healthy microbiota requires the proper designation of the microbial
variability, which is a prerequisite and is a deviation from the disease states. Majority of the
microbes reside on the human body and is exposed to the environment, whereas a larger section
of the microbes resides in the intestinal tract. Microbial communities are found on the skin, in the
vagina, and in the mouth. Bacterial communities that reside in similar sites of the body resemble
in their characteristics. The microbes that are found in the mouth are similar in comparison to the

4SCIENTIFIC PRACTICE AND COMMUNICATION
microbes that are found in the mouth and skin surface. Especially the gut microbiota is
dominated by the specific members like Firmicutes and Bacteroidetes (Lynch and Pedersen
2016). There is a huge difference between the taxa present in the gut and the microbial
composition of individual microbes. The most common microbiota that are found in the human
gut are the enterotypes and it consists of the Ruminococcus or Prevotella and Bacteroides. These
microbial compositions are generally driven by the by the dietary effects. Studies have indicated
that the dietary composition has significantly impacted the human microbiota. Also, the diet has
a positive relation with the enterotype. It has been seen that the diet with high quantity of animal
fat have the enterotype dominated by Bacteroides. However, in carbohydrate rich diet the diet is
associated with the enterotype dominated by Prevotella. Gut inflammatory disease is also termed
as crohn’s disease. This disease is characterized by the chronic gastrointestinal disorder and it
results in to an inflammatory response in the intestinal mucosa. There are studies that highlight
how the microbiota, genome and virome plays a role in interacting with the development of the
crohn’s disease (Shreiner, Kao and Young 2015).
Literature review
Microbiome and its metabolites in disease and health
There are two major clinical phenotypes with respect to intestinal bowel phenotype. The
first one is the crohn’s disease and the second one is the ulcerative colitis. In humans, studies
have show there is an increased biodiversity of the Enterobacteriaceae and Bateroides and less
abundance of the Firmicutes (Clemente, Manasson and Scher 2018). Is has been seen that
Roseburia hominis and Firmicutes prausnitzii are found to be producing butyrate and is thus
known to produce the Treg via the receptor of GRR43. Both the taxa are seen to be linked
inversely with the ulcerative colitis and furthermore it has been seen that the

5SCIENTIFIC PRACTICE AND COMMUNICATION
Phascolarctobacterium is capable of producing propionate and it produces propionate in the
presence of Paraprevotella and in turn this induces the Tregs. However, there are other pathobionts
that are enhanced in the intestinal bowel diseases, and this includes the Heliobacter hepaticus,
Proteus mirabilis, Klebsiella pneumoniae and Clostridium difficile, Prevotellaceae,
Stenotrophomonas maltophilia, Rhodococcus, Shigella and Escherichia coli (Liang et al. 2018).
The dysbiotic shift is found to be in the favor of pathobionts and this contributes positively to the
perturbations and affects the immune function of the lamina propria cells, which ultimately
results into the inflammatory response and progress of the disease. Survey’s carried out on the
microbiome of several patients have shown that the Fusobacteriaceae, Neisseriaceae,
Veillonellaceae, Pasteurellaceae, Clostidiales, Bacteriodales, Enterobacteriaceae are found to be
exhibiting a positive correlation with the disease. However, Coprococus, Ruminococcus, Blautia,
Roseburia, Faecalibacterium, Bacteroides, Ruminococcaceae, Lacnospiraceae are found to be
negatively coorelated with the biopsy samples that are collected from rectum and ileum. While
excess exposure to the antibiotics increase the microbial dysbiosis. Specifically, the bacteria that
are coated with the IgA increases the susceptibility of a human to gut inflammatory disease
(Wang et al. 2017).
Gut inflammatory disease
Inflammatory bowel disease is a perfect example of gut-microbe disease. Inflammatory
bowel disease can be described as the recurring, persistent, idiopathic, and a multifactoral
gastrointestinal inflammation. Whereas the two most common type of Inflammatory bowel
disease are: Crohn’s disease and ulcerative colitis. In the Crohn’s disease it has been seen that
the inflammation occurs along the gastro-intestinal tract. While the in ulcerative colitis, the
inflammation is restricted only to the large intestine. The incidence of the gastro-intestinal

6SCIENTIFIC PRACTICE AND COMMUNICATION
inflammation is due to the imbalances in the population of the gut microbes. While studies have
indicated that the large number of the Inflammatory bowel disease occurs due to the gut
dysbiosis and the increased gut pathogenesis (Nagao-Kitamoto et al. 2016a). The evidences of
dysbiosis is commonly observed in the intestinal bowel disease with the reduction in the
population of the Faecalibacterium prausnitizii, Firmicutes sp. and Roseburia sp. These bacteria
are found to play a major role in the in reducing the anti-inflammatory responses along with the
reduction in the pro-cytokines. Besides it is also important to mention that the Faecalibacterium
prausnitizii, Firmicutes sp. and Roseburia sp produces the butyrates that acts as an energy
substrate for the colonocytes. Thus, it can be said that if the Faecalibacterium prausnitizii,
Firmicutes sp. and Roseburia sp population in the gut reduces then there is a chance of increasing
local inflammation. The Firmicutes are found to be the important regulator of mucosal immunity.
Another highlighting fact came forward through the studies is the overall increase in the
population of the Bacteroides fragilis and Enterobacteriaceae both have a high level of endotoxic
LPS on their external membrane. Researches have shown that the high level of endotoxic LPS
that are expressed by microbiota is shown to increase gut inflammation and the development of
the colitis in mice. This occurs either through the activation of the effector Helper-T or by the
suppression of the regulatory T-Lymphocyte and it takes place by the TLR4 signaling pathway
(Kho and Lal 2018) (appendix 1).
Dysbiosis and disease
It is a well-established fact that microbial biota plays a major role in the resistance
towards the pathogenic microorganism and augments the intestinal epithelium. It has been found
that the intestinal epithelial cells have the requisite places of contact for the microbial biota that
acts to prevent the systemic translocation of substances. Intestinal epithelial cells have the

7SCIENTIFIC PRACTICE AND COMMUNICATION
lymphoid cells associated with the gut (GALT). GALT is rich in adaptive and innate immune
system that helps in maintaining the gut homeostasis. GALT interacts with the intestinal cells
and recognizes the pathogenic bacteria through the pattern recognition method. The patter
recognition methods employed are the Nucleotide binding oligomerization domain (NOD) and
Toll like receptors (TLRs). Studies have shown that the innate immune receptors have the proper
structures that can identify both the commensal bacteria and pathogenic bacteria (Bernstein and
Forbes 2017). While, it is important to mention a vital and important relationship exists between
the commensal bacteria and intestinal epithelium and the relationship between the intestinal
microbes and the human host is found to be healthy and symbiotic in nature. Thus, when the
symbiotic relationship gets disrupted due to the alterations and interactions, there is a huge
probability of the occurrence of dysbiosis, this promotes diseases state and human health is
negatively affected. The gastrointestinal cells are protected by a mucus covering and it consists
of the mucus glycoproteins which is synthesized by the goblet cells (Boulangé et al. 2016).
These goblet cells get directly affected by the release of bioactive factors mucus are secreted
during the process of fermentation by the microorganisms that are beneficial. The intestinal
microbes have the potential to directly affect the goblet cells and it led to gut inflammation
diseases. There are several diseases that are associated with the gut microbiota and the
imbalances leads to the vaginosis, antibiotic associated diarrhea, tropical enteropathy, IBS,
chronic periodontitis, inflammatory bowel disease and obesity. Both the increase and decrease in
the number of the gut microbes is seen to be associated with the inflammatory bowel disease
(Bakhtiar et al. 2013) (appendix 2).
Health intervention by microbiota manipulation

8SCIENTIFIC PRACTICE AND COMMUNICATION
When probiotics is considered, the Bifidobacterium and Lactobacillus are the two most
beneficial for the human health. In children, Lactobacillus is known to prevent antibiotic
associated diarrhea and at the same time prevents the growth of Lactobacillus rhamnosus GG
and is also seen to prevent the growth of Helicobacter Pylori. Similarly, Bifidobacterium lactis is
capable of promoting the human responses towards the human rotavirus. At least 9 different
species of Bifidobacterium are identified to be commonly associated with the human gut
(Clemente et al. 2012). Studies have shown that during a pathological condition of irritable
bowel syndrome, inflammatory bowel disease and colorectal cancer, there is significant increase
or decrease in the number of the Bifidobacterium in the human gut in comparison to the other
microbes. Bifidobacterium is found to be interacting with cells of the intestine and this helps in
inflammatory gene expression and immunity regulation. Studies have shown that the
Bifidobacterium longum is capable of regulating the IL-1 alpha expression and regulation of the
TNF-alpha in the patients that are suffering from the ulcerative colitis (Appendix 3). Even
research in this field have shown that the probiotics has its usage in arenas other than the
conventional reduction of harm. Microbial transplantation is one such method that enhance the
therapeutic efficiency and the restoration of the gut microbes through transplantation to counter
the Clostridium difficile colitis (Jin, Zhang and Sun 2014).
Conclusion
From the above discussion it can be concluded that the most common microbes that are
found to be interacting with the human immune system are the eukaryotes, viruses and bacteria
and this plays an influential role in the development of diseases. Studies have indicated that a
human body harbors about 100 trillion microbial cells. Thus, it is no denying that the human
microbiota plays a decisive role in the both the maintenance of health and development of

9SCIENTIFIC PRACTICE AND COMMUNICATION
diseases. microbial compositions are generally driven by the by the dietary effects. Studies have
indicated that the dietary composition has significantly impacted the human microbiota. Also, the
diet has a positive relation with the enterotype. It has been seen that the diet with high quantity of
animal fat have the enterotype dominated by Bacteroides. Identification of the healthy
microbiota requires the proper designation of the microbial variability, which is a prerequisite
and is a deviation from the disease states. Majority of the microbes reside on the human body
and is exposed to the environment, whereas a larger section of the microbes resides in the
intestinal tract.

10SCIENTIFIC PRACTICE AND COMMUNICATION
Reference
Bakhtiar, SM, LeBlanc, J G., Salvucci, E, Ali, A, Martin, R, Langella, P, Azevedo, V (2013).
Implications of the human microbiome in inflammatory bowel diseases. FEMS
microbiology letters, 342(1), 10-17. DOI: https://doi.org/10.1111/1574-6968.12111
Bernstein, C N, Forbes, J D (2017). Gut Microbiome in Inflammatory Bowel Disease and Other
Chronic Immune-Mediated Inflammatory Diseases. Inflammatory Intestinal
Diseases, 2(2), 116-123. DOI: https://doi.org/10.1159/000481401
Boulangé, C L, Neves, A L, Chilloux, J, Nicholson, J K, & Dumas, M E (2016). Impact of the
gut microbiota on inflammation, obesity, and metabolic disease. Genome medicine, 8(1),
42. DOI: https://doi.org/10.1186/s13073-016-0303-2
Clemente, J C, Manasson, J, Scher, J U (2018). The role of the gut microbiome in systemic
inflammatory disease. Bmj, 360, j5145. DOI: 10.1136/bmj.j5145
Clemente, J C, Ursell, L K, Parfrey, L. W, Knight, R (2012). The impact of the gut microbiota on
human health: an integrative view. Cell, 148(6), 1258-1270. DOI:
https://doi.org/10.1016/j.cell.2012.01.035
Jin, D, Zhang, H, Sun, J (2014). Manipulation of microbiome, a promising therapy for
inflammatory bowel diseases. J Clin Cell Immunol, 5, 234. DOI: 10.4172/2155-
9899.1000234
Kho, Z Y, Lal, S K (2018). The Human Gut Microbiome–A Potential Controller of Wellness and
Disease. Frontiers in microbiology, 9. DOI: https://doi.org/10.3389/fmicb.2018.01835

11SCIENTIFIC PRACTICE AND COMMUNICATION
Kostic, A D, Xavier, R J, Gevers, D (2014). The microbiome in inflammatory bowel disease:
current status and the future ahead. Gastroenterology, 146(6), 1489-1499. DOI:
https://doi.org/10.1053/j.gastro.2014.02.009
Liang, D, Leung, R K K, Guan, W, Au, W W (2018). Involvement of gut microbiome in human
health and disease: brief overview, knowledge gaps and research opportunities. Gut
pathogens, 10(1), 3. DOI: https://dx.doi.org/10.1186%2Fs13099-018-0230-4
Lynch, S V, Pedersen, O (2016). The human intestinal microbiome in health and disease. New
England Journal of Medicine, 375(24), 2369-2379. DOI: 10.1056/NEJMra1600266
Nagao-Kitamoto, H, Shreiner, A B, Gillilland III, M G, Kitamoto, S, Ishii, C, Hirayama, A,
Higgins, P D (2016a). Functional characterization of inflammatory bowel disease–
associated gut dysbiosis in gnotobiotic mice. Cellular and molecular gastroenterology
and hepatology, 2(4), 468-481. DOI: https://doi.org/10.1016/j.jcmgh.2016.02.003
Nagao-Kitamoto, H, Shreiner, A, Gillilland, M, Kitamoto, S, Kuffa, P, Seekatz, A M, Kamada,
N (2016b). Su1898 Inflammatory Bowel Disease-Associated Gut Dysbiosis Impacts the
Host Physiology and Colitis in Gnotobiotic Mice. Gastroenterology, 150(4), S582-S583.
DOI: https://doi.org/10.1016/S0016-5085(16)31997-7
Scher, J U, Ubeda, C, Artacho, A, Attur, M, Isaac, S, Reddy, S M, Manasson, J (2015).
Decreased bacterial diversity characterizes the altered gut microbiota in patients with
psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis &
rheumatology, 67(1), 128-139. DOI: https://doi.org/10.1002/art.3892

12SCIENTIFIC PRACTICE AND COMMUNICATION
Shreiner, A B, Kao, J Y, Young, V B (2015). The gut microbiome in health and in
disease. Current opinion in gastroenterology, 31(1), 69. DOI:
https://dx.doi.org/10.1097%2FMOG.0000000000000139
Wang, B, Yao, M, Lv, L, Ling, Z, Li, L (2017). The human microbiota in health and
disease. Engineering, 3(1), 71-82. DOI: https://doi.org/10.1016/J.ENG.2017.01.008

13SCIENTIFIC PRACTICE AND COMMUNICATION
Appendix
Appendix 1[source: Kho and Lal 2018]
Appendix 2: [Bakhtiar et al. 2013]

14SCIENTIFIC PRACTICE AND COMMUNICATION
Appendix 3: [source: Clemente, Manasson and Scher 2018]